Latest News and Press Releases

NEWTON, MA--(Marketwired - Dec 29, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) released final trial results from its proof of concept (POC) Sydney University study that showed consumption of...

NEWTON, MA--(Marketwired - Nov 20, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE), a leading developer of novel compounds based on complex carbohydrate chemistry for the treatment of metabolic...

MANCHESTER, NH--(Marketwired - Oct 6, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd. (APC), completed enrollment...

MANCHESTER, NH--(Marketwired - Sep 29, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) (the "Company") announced that on September 24, 2015, the Company paid in-full all of the Company's...

MANCHESTER, NH--(Marketwired - Sep 15, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd. (APC), is conducting a...

MANCHESTER, NH--(Marketwired - Aug 13, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE), a leading developer of novel compounds based on complex carbohydrate chemistry for the treatment of diabetes...

MANCHESTER, NH--(Marketwired - Aug 6, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes...

MANCHESTER, NH--(Marketwired - Jul 8, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) today announced that its Hong Kong affiliate, Advance Pharmaceutical Company, Ltd. (APC), is conducting a...

MANCHESTER, NH--(Marketwired - Jun 8, 2015) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes and...

MANCHESTER, NH--(Marketwired - May 28, 2015) -  Boston Therapeutics, Inc. (OTCQB: BTHE) signed a Letter of Intent with Dr. Gene D. Morse, Director of the Translational Pharmacology Research...